Foundation Medicine Email Format
Biotechnology ResearchMassachusetts, United States1001-5000 Employees
Foundation Medicine is a global biotechnology research company focused on precision medicine, delivering diagnostic solutions for cancer and other diseases. The company provides tests and solutions that span diagnosis, treatment selection, and ongoing monitoring, leveraging precision medicine knowledge, real-world data, and AI-powered tools to inform care. It is based in Boston, Massachusetts (400 Summer Street, 02210) and employs between 1,001 and 5,000 people, operating as an independent subsidiary of Roche. Through collaborations with Bristol Myers Squibb, Foundation Medicine is developing FoundationOne CDx as a next-generation sequencing–based companion diagnostic to identify patients with homozygous MTAP deletion across multiple indications for an investigational targeted therapy, and it is also developing an MTAP biomarker test. In 2026, the company expanded its capabilities through the acquisition of Saga Diagnostics AB and partnerships to combine data assets for life sciences research.
1-888-653-2347 
support@leadiq.com 
